Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)

Legend Biotech (LEGN) has reported Other Non Operating Income for 6 consecutive years, with -$2.4 million the latest figure, recorded in Q4 2025.

• Other Non Operating Income for Q4 2025 came in at -$2.4 million, down 102.15% year-over-year; the trailing twelve-month figure through Dec 2025 was -$164.7 million (down 247.22% YoY), and the FY2025 annual result was -$164.8 million, down 247.41% from the prior year.
• Other Non Operating Income was -$2.4 million for Q4 2025 at Legend Biotech, down from $354000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $111.4 million in Q4 2024 and troughed at -$108.1 million in Q2 2025.
• Average Other Non Operating Income over 5 years is -$166400.0, with a median of $2.6 million recorded in 2021.
• Year-over-year, Other Non Operating Income soared 7474.24% in 2021 and tumbled 969.55% in 2025.
• Over 5 years, Other Non Operating Income stood at $4.9 million in 2021, then jumped by 88.19% to $9.2 million in 2022, then soared by 318.52% to $38.3 million in 2023, then jumped by 190.62% to $111.4 million in 2024, then sank by 102.15% to -$2.4 million in 2025.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$2.4 million in Q4 2025, $354000.0 in Q3 2025, and -$108.1 million in Q2 2025.